COMPARATIVE ANALYSIS OF CISPLATIN TOLERABILITY IN HEAD AND NECK, BLADDER, AND CERVICAL CANCERS: DOES THE PRIMARY TUMOR SITE INFLUENCE TOXICITY PROFILES?

MUSTAFA ERSOY

Journal of Bionic Memory - 2025;5(2):24-31

Aim: This study aims to investigate whether there is a difference in the tolerance of the cisplatin-radiotherapy regimen between head and neck cancers and bladder/cervical cancers. This will help determine if the typical tolerability issues associated with the cisplatin-radiotherapy combination are the primary barrier to delivering the desired cisplatin dose, or if the sensitive anatomical location of head and neck cancers leads to even poorer tolerance compared to other tumor sites.